Inhibition of intraocular fibrin formation following infusion of low-molecular-weight heparin during vitrectomy
- PMID: 2003803
- DOI: 10.1001/archopht.1991.01080030107048
Inhibition of intraocular fibrin formation following infusion of low-molecular-weight heparin during vitrectomy
Abstract
We studied the inhibition of intraocular fibrin formation following infusion of 5 IU/mL of low-molecular-weight heparin sodium (Fragmin, KabiVitrum AB, Stockholm, Sweden) during lensectomy, vitrectomy, and retinotomy in the rabbit model. Surgery was performed on 18 eyes, with nine receiving low-molecular-weight heparin and nine serving as controls. Masked postoperative examinations assessed fibrin quantity, corneal clarity, media clarity, and amount of vitreous hemorrhage. Five (56%) of nine eyes receiving low-molecular-weight heparin did not show fibrin exudation development, with the remainder demonstrating a minimal fibrin response. Eight (89%) of nine control eyes demonstrated prominent fibrin exudation, with five (56%) showing development of a fibrin clot that obscured two or more quadrants of the posterior chamber. No significant difference in the degree of vitreous hemorrhage was noted between groups. Corneal clarity was improved in the heparin-treated group.
Similar articles
-
A prospective, randomized, clinical trial of heparin therapy for postoperative intraocular fibrin.Ophthalmology. 1988 Mar;95(3):312-7. doi: 10.1016/s0161-6420(88)33181-7. Ophthalmology. 1988. PMID: 3173998 Clinical Trial.
-
Heparin prophylaxis for intraocular fibrin.Ophthalmology. 1987 Jun;94(6):597-601. doi: 10.1016/s0161-6420(87)33403-7. Ophthalmology. 1987. PMID: 3627708
-
Complications associated with clear corneal cataract wounds during vitrectomy.Retina. 2010 Jun;30(6):850-5. doi: 10.1097/IAE.0b013e3181c70111. Retina. 2010. PMID: 20090563
-
Intraocular injection of recombinant hirudin to prevent experimental postoperative fibrin.Retina. 1997;17(4):315-20. doi: 10.1097/00006982-199707000-00007. Retina. 1997. PMID: 9279948
-
Combined extracapsular cataract extraction, posterior chamber intraocular lens implantation, and pars plana vitrectomy.Ophthalmic Surg. 1993 Jul;24(7):446-52. Ophthalmic Surg. 1993. PMID: 8351090 Review.
Cited by
-
[Proliferative vitreoretinopathy prophylaxis : Mission (im)possible].Ophthalmologe. 2021 Jan;118(1):3-9. doi: 10.1007/s00347-020-01173-8. Ophthalmologe. 2021. PMID: 32666172 Review. German.
-
Transplantation of congenitally opaque corneas.Br J Ophthalmol. 1997 Dec;81(12):1064-9. doi: 10.1136/bjo.81.12.1064. Br J Ophthalmol. 1997. PMID: 9497466 Free PMC article.
-
A prospective, open-label, dose-escalating study of low molecular weight heparin during repeat vitrectomy for PVR and severe diabetic retinopathy.Graefes Arch Clin Exp Ophthalmol. 2005 Jul;243(7):701-5. doi: 10.1007/s00417-004-0912-0. Epub 2005 Mar 3. Graefes Arch Clin Exp Ophthalmol. 2005. PMID: 15744529
-
Intracameral tissue plasminogen activator to prevent severe fibrinous effusion after congenital cataract surgery.Br J Ophthalmol. 2005 Nov;89(11):1458-61. doi: 10.1136/bjo.2005.071407. Br J Ophthalmol. 2005. PMID: 16234453 Free PMC article. Clinical Trial.
-
Effect of low molecular weight heparin (enoxaparin) on congenital cataract surgery.Int J Ophthalmol. 2012;5(5):596-9. doi: 10.3980/j.issn.2222-3959.2012.05.10. Epub 2012 Oct 18. Int J Ophthalmol. 2012. PMID: 23166871 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical